No Data
No Data
Express News | NYSE Order Imbalance 117193.0 Shares on Sell Side
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
Throughout the last three months, 5 analysts have evaluated Abbott Laboratories (NYSE:ABT), offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview of re
Abbott Labs Is Maintained at Buy by Citigroup
Abbott Labs Is Maintained at Buy by Citigroup
Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $119
Citigroup analyst Joanna Wiensch maintains Abbott Laboratories with a Buy and lowers the price target from $128 to $119.
Abbott Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 13.61% Citigroup $128 → $119 Maintains Buy 04/22/2024 33.66% Barclays $141 → $140 Maintains Ove
Express News | Abbott : Citigroup Cuts Target Price to $119 From $128
No Data